Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02196922 · ClinicalTrials.gov registry record · NA

Telehealth Management in HF Disparity Patients

A NA study of Chronic Heart Failure, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
104
Enrollment target
1
Study location

NCT02196922: Completed NA study of Chronic Heart Failure, sponsored by Northwell Health.

NCT02196922 is a NA study of Chronic Heart Failure that has completed, run by Northwell Health. The registered enrollment target is 104 participants, below the 414-participant average among 12 other Chronic Heart Failure trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02196922, a NA study of Chronic Heart Failure, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target
1
Study location

Study Summary

In the US, racial and ethnic disparities persist, even when income, health insurance and care access are addressed. For example, there is a greater prevalence of chronic heart failure (CHF), higher rates of hospital use and higher death rates in blacks as compared to whites. This is due to many factors including: reduced healthcare access, higher prevalence of hypertension,coronary artery disease, systolic dysfunction, myocardial infarction and obesity. Given the magnitude of this chronic health issue, the growth of the elderly population, and increases in ethnic diversity, providers need to develop new ways of caring for those with chronic conditions living in health disparity communities. The investigators propose to implement a randomized study with health disparity community-dwelling patients. A bilingual clinician will follow patients for 3 months after hospitalization for CHF to test this approach for the proposed health disparity population. The investigators will obtain patient/caregiver input at multiple points during the research to make necessary adjustments to the intervention to ensure that disparity patients accept/use the system, and are satisfied. To ensure that proposed outcomes have relevance for patients, a Community Advisory Board (CAB) of stakeholders will advise the study team throughout the study process. The investigators believe that studying patient use of TSM over a 3 month period will: 1) identify cost-effective care approaches for patients living with chronic disease; 2) involve the patient in identifying and testing approaches that work for them; 3) enhance provider-patient communication; 4) teach the patient how to self-monitor and explore his/her role in self-care; 5) improve patient education about treatment options and 6) explore how "usable" the patients feel the program is. If our goals are achieved, these strategies will result in patient-led improvements in health, satisfaction and quality of life. Knowledge gained will further

Primary Outcome

Number of hospitalizations during the 90 day observation period

Conditions Studied

Interventions

  • OTHER Standard of Care
  • DEVICE Telehealth Self Management (TSM)

Study Locations (1)

New York

  • Nassau University Medical Center - East Meadow

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2014-01-01
Est. Completion 2017-04-30
Phase NA
Northwell Health

370 total trials

What the finished NCT02196922 record still lists

NCT02196922 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 414-participant average among 12 other Chronic Heart Failure trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Chronic Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT02196922 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02196922 about?

NCT02196922 is a clinical study titled "Telehealth Management in HF Disparity Patients". In the US, racial and ethnic disparities persist, even when income, health insurance and care access are addressed. For example, there is a greater prevalence of chronic heart failure (CHF), higher rates of hospital use and higher death rates in blacks as compared to whites. This is due to many fact...

What is the current status of trial NCT02196922?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2014-01-01. Estimated completion is 2017-04-30.

What conditions does trial NCT02196922 study?

This clinical trial studies the following conditions: Chronic Heart Failure.

What interventions are being tested in trial NCT02196922?

The interventions under investigation include: Standard of Care (OTHER), Telehealth Self Management (TSM) (DEVICE).

Who is sponsoring clinical trial NCT02196922?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02196922 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02196922's enrollment target sits among peer trials

104 9th of 12 higher than 4 of 12 other Chronic Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03403686 · 104 participants

    Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)

  • NCT04228367 · 104 participants · NA

    JuggerStitch Post Market Clinical Follow-up Study

  • NCT04268849 · 104 participants · Phase 3

    Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient

  • NCT04390724 · 104 participants

    Optimizing Y90 Therapy for Radiation Lobectomy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02196922, the US trial registry maintained by the National Library of Medicine. NCT02196922 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.